Lataa...
T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer’s Disease
BACKGROUND: T3D-959, a dual PPAR-δ/PPAR γ nuclear receptor agonist and former diabetes drug candidate, has been repositioned as an Alzheimer’s disease (AD)-modifying therapy. OBJECTIVE: This study examines the effectiveness and mechanisms of T3D-959’s therapeutic effects using in vivo and ex vivo ra...
Tallennettuna:
| Julkaisussa: | J Alzheimers Dis |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5577391/ https://ncbi.nlm.nih.gov/pubmed/26836193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-151013 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|